Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Replimune Group, Inc. (REPL)

Replimune prices $150 million stock offering at $12.06 per share

Neutral Impact 3 of 5 financing Written later

Replimune agreed on August 9, 2026 to sell 9,701,490 common shares and pre-funded warrants for 2,736,340 shares to underwriters at $12.06 per share. The company expects gross proceeds of about $150 million and net proceeds of about $140.5 million, with closing expected on August 11, 2026. Because the sale adds shares to those already outstanding, existing shareholders' ownership stake will be diluted.

Key points

  • Offering of 9,701,490 common shares at $12.06 per share, plus pre-funded warrants for 2,736,340 shares at $12.0599 per warrant
  • Expected gross proceeds of about $150 million; estimated net proceeds of about $140.5 million after underwriting discounts and offering expenses
  • Underwriters are Leerink Partners LLC, J.P. Morgan Securities LLC, and Cantor Fitzgerald & Co.; closing expected on or about August 11, 2026

The filing

CompanyReplimune Group, Inc. (REPL)
Form8-K, current report
Filed with the SECAug 10, 2026, 7:50 AM ET
Accession number0001104659-26-093042

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.